CS logo
small CS logo
Rocky Mountain Cancer Centers-Rose

Denver, Colorado, United States
Cancer treatment center in Denver, Colorado
4700 E Hale Pkwy Ste. 400, Denver, CO 80220

About Rocky Mountain Cancer Centers-Rose


"Rocky Mountain Cancer Centers (RMCC) is Colorado's largest and most comprehensive provider of cancer care with over 50 physicians, in nearly 20 community-based locations across the state. Our history is rich in forward thinking and best practice development. We were formed in 1992 when a group of independent medical oncology practices joined together to become a network of community-based clinic sites. This practice model has stood the test of time and continues to have proven clinical and economic benefit for patients, employers and payers today."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
72
SWOG Cancer Research Network
30
Alliance for Clinical Trials in Oncology
23
ECOG-ACRIN Cancer Research Group
13
Eastern Cooperative Oncology Group
6
NRG Oncology
6
US Oncology Research
4
GOG Foundation
3
Gynecologic Oncology Group
2
Children's Oncology Group
1
Eisai Inc.
1
Total Rows: 17

Clinical Trials at Rocky Mountain Cancer Centers-Rose


During the past decade, Rocky Mountain Cancer Centers-Rose conducted 90 clinical trials. In the 10-year time frame, 90 clinical trials started and 64 clinical trials were completed, i.e. on average, 71.1% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 42 clinical trials were completed. i.e. 200% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years771111202016161515141466110088332299111115151212Started TrialsCompleted Trails201520162017201820192020202120220102030
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia
1999-12-01
Completed
280
Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer
2003-05-01
Completed
Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer
2002-10-01
2005-02-04
Completed
21
Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer
2002-10-29
2009-05-01
Completed
Modafinil in Treating Fatigue in Patients Receiving Chemotherapy for Cancer
2002-08-01
2007-10-01
Completed
837
Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
2003-03-01
Completed
A Phase II Study of E7389 in Patients With Breast Cancer, Previously Treated With Anthracycline, Taxane and Capecitabine
2005-10-01
2007-09-01
Completed
298
PhII ICb With/Without Erbitux in MBC Pts
2005-07-28
2022-12-01
Active, not recruiting
154

Rows per page:

1–100 of 167

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Rocky Mountain Cancer Centers-Rose" #1 sponsor was "National Cancer Institute (NCI)" with 72 trials, followed by "SWOG Cancer Research Network" with 30 trials sponsored, "Alliance for Clinical Trials in Oncology" with 23 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 13 trials sponsored and "Eastern Cooperative Oncology Group" with 13 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 17 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Rocky Mountain Cancer Centers-Rose" #1 collaborator was "National Cancer Institute (NCI)" with 86 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator and "SWOG Cancer Research Network" with 3 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 26 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNational CancerInstitute (NCI): 72National CancerInstitute (NCI): 72SWOG Cancer ResearchNetwork: 30SWOG Cancer ResearchNetwork: 30Alliance for ClinicalTrials in Oncology: 23Alliance for ClinicalTrials in Oncology: 23ECOG-ACRIN CancerResearch Group: 13ECOG-ACRIN CancerResearch Group: 13Eastern CooperativeOncology Group: 6Eastern CooperativeOncology Group: 6NRG Oncology: 6NRG Oncology: 6US Oncology Research: 4US Oncology Research: 4GOG Foundation: 3GOG Foundation: 3Gynecologic Oncology Group: 2Gynecologic Oncology Group: 2Children's Oncology Group: 1Children's Oncology Group: 1

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 86National CancerInstitute (NCI): 86NRG Oncology: 16NRG Oncology: 16Canadian Cancer Trials Group: 8Canadian Cancer Trials Group: 8Cancer and LeukemiaGroup B: 3Cancer and LeukemiaGroup B: 3SWOG Cancer ResearchNetwork: 3SWOG Cancer ResearchNetwork: 3Pfizer: 2Pfizer: 2Sanofi: 2Sanofi: 2Agenus Inc.: 1Agenus Inc.: 1AstraZeneca: 1AstraZeneca: 1Austrian Breast &Colorectal Cancer StudyGroup (ABCSG): 1Austrian Breast &Colorectal Cancer StudyGroup (ABCSG): 1

Clinical Trials Conditions at Rocky Mountain Cancer Centers-Rose


According to Clinical.Site data, the most researched conditions in "Rocky Mountain Cancer Centers-Rose" are "Invasive Breast Carcinoma" (10 trials), "Breast Cancer" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Recurrent Ovarian Carcinoma" (8 trials) and "Stage IV Lung Cancer AJCC v8" (8 trials). Many other conditions were trialed in "Rocky Mountain Cancer Centers-Rose" in a lesser frequency.

Clinical Trials Intervention Types at Rocky Mountain Cancer Centers-Rose


Most popular intervention types in "Rocky Mountain Cancer Centers-Rose" are "Drug" (131 trials), "Other" (106 trials), "Biological" (70 trials), "Procedure" (43 trials) and "Radiation" (13 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (53 trials), "Quality-of-Life Assessment" (44 trials), "Questionnaire Administration" (25 trials), "Biospecimen Collection" (23 trials) and "Computed Tomography" (23 trials). Other intervention names were less common.

Clinical Trials Genders at Rocky Mountain Cancer Centers-Rose


The vast majority of trials in "Rocky Mountain Cancer Centers-Rose" are 129 trials for "All" genders, 34 trials for "Female" genders and 4 trials for "Male" genders.

Clinical Trials Status at Rocky Mountain Cancer Centers-Rose


Currently, there are NaN active trials in "Rocky Mountain Cancer Centers-Rose". undefined are not yet recruiting, 38 are recruiting, 77 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 41 completed trials in Rocky Mountain Cancer Centers-Rose, 5 suspended trials, and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Rocky Mountain Cancer Centers-Rose, 3 "Phase 1" clinical trials were conducted, 76 "Phase 2" clinical trials and 90 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 90Phase 3: 90Phase 2: 76Phase 2: 76Not Applicable: 4Not Applicable: 4Phase 1: 3Phase 1: 3Early Phase 1: 2Early Phase 1: 2

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 77Active, not recruiting: 77Completed: 41Completed: 41Recruiting: 38Recruiting: 38Suspended: 5Suspended: 5Terminated: 5Terminated: 5Unknown status: 1Unknown status: 1